Program Curriculum 

Our pharmacy residency program provides a strong foundation for residents to build their clinical skills at training sites that value inter-professional collaboration and medical education. Residents will participate in providing care to a diverse population of patients and addressing the healthcare needs of the Central Valley. 

Required learning experiences are scheduled at each resident’s respective home-based site while elective learning experiences are available to all residents at both sites. Each rotation’s duration is 4-6 weeks. 

Learning Experiences

Required Rotations

• Hospital Operations I/II
• Internal Medicine
• Medicine Intensive Care Unit (MICU)
• Emergency Medicine
• Hospital Administration

Elective Rotations

• Medication Safety
• Clinical Informatics
• Supply Chain Management
• Quality/Risk Management
• Burn/Surgery ICU
• Neuro ICU
• Trauma/Surgery ICU
• Pediatrics
• Neonatal ICU
• Infectious Diseases
• Inpatient Oncology
• Outpatient Oncology
• Women & Children’s

Longitudinal Resident Projects

• Pharmacy Education Seminar (1.0 CE accredited)
• Drug Monograph
• Research
• Hospital Operations Staffing

Additional Resident Opportunities

• Teaching Certificate
• Basic Life Support (BLS) Training & Certification
• Advanced Cardiac Life Support (ACLS) Training & Certification
• Pediatric Advanced Life Support (PALS) Training & Certification

Previously Completed Longitudinal Resident Projects

Pharmacy Education Seminars (1.0 CE accredited)

• BiTE vs. CAR-T: A New Frontier in Hematological Malignancies

• Less Blood, More Boost: Epoetin Alfa as an Alternative to Blood Transfusions

• Stopping Clots in Their Tracks: The 2023 ASCO Update for Cancer Patients

• When Contrast Meets the Kidneys: A Deep Dive into Contrast-Induced Acute Kidney Injury

• Pharmacy Department – “Ertapenem Quality Assurance Project”

Drug Monographs

• Aminolevulinic Acid (Gleolan)

• Elranatamab-bcmm (Elrexfio)

• Anacaulase-bcdb (NexoBrid)

• Sulbactam/Durlobactam (Xacduro)

Research

• Outcomes for patients on midazolam-based sedation vs. non-midazolam-based sedation in paralyzed ARDS patients

• Identify risk factors leading to supra-therapeutic gentamicin peak level in neonatal patients with gestational age less than and equal to 29 weeks receiving gentamicin for suspected congenital sepsis

• Evaluation of the Rate of Hemorrhagic Transformation After Stroke Thrombolysis with Alteplase versus Tenecteplase

• Comparative Analysis of Adverse Effects for Dopamine Versus Norepinephrine in the Treatment of Septic Shock